Parasite Immunology, 2013, 35, 283–294                                                                          DOI: 10.1111/pim.12046



Review Article

Imaging African trypanosomes

L. MACLEAN,1 E. MYBURGH,2 J. RODGERS3 & H. P. PRICE1

1
 Centre Immunology Infection, Department Biology/Hull York Medical School, University York, Heslington, York, UK,
2
 Wellcome Trust Centre Molecular Parasitology, Institute Infection, Immunity Inflammation, College Medical, Veterinary &
Life Sciences, University Glasgow, Glasgow, UK, 3Institute Infection, Immunity Inflammation, College Medical, Veterinary &
Life Sciences, University Glasgow, Glasgow, UK




SUMMARY
                                                                        INTRODUCTION
Trypanosoma brucei extracellular kinetoplastid para-
sites transmitted blood-sucking tsetse fly.             Human African trypanosomiasis (HAT) caused responsible fatal disease human African trypanosomi-            infection African trypanosomes (Trypanosoma
asis (HAT), known sleeping sickness. late-stage              brucei), transmitted haematophagous
infection, trypanosomes cross blood–brain barrier                   tsetse fly (Glossina spp.). subspecies human infec-
(BBB) invade central nervous (CNS)                       tive: Trypanosoma brucei gambiense, present invariably leading coma death untreated.             West Central Africa, Trypanosoma brucei rhodes- available vaccine current late-stage HAT chemother-              iense, East Southern Africa.
apy consists melarsoprol, highly toxic               Human African trypanosomiasis characterized causing 8  deaths, nifurtimox–eflornithine com-             stages, early haemolymphatic stage trypano-
bination therapy (NECT), costly difficult               somes proliferate bite site, travel local lymph
administer. urgent need identify new           nodes establish infection bloodstream, late-stage HAT drug candidates.  review                     late meningoencephalitic stage trypanosomes
current imaging tools, ranging fluorescent confocal                cross blood–brain barrier (BBB) invading central
microscopy live immobilized cells culture                nervous (CNS). late stage invariably leads animal imaging, providing insight T. brucei biology,           coma death untreated (1, 2). Human African
parasite-host interplay, trypanosome CNS invasion                   trypanosomiasis severe social economic
disease progression. consider imaging tools             impact sub-Saharan Africa estimated 70 used candidate drug screening purposes                million people risk infection. Investment control
lead new chemotherapies.                                             strategies decade led significant
                                                                        decline recorded HAT cases <10 000 cases
Keywords animal model, electron microscopy, vivo imag-               reported 2009 time 50 years
ing, RNA interference, tools techniques, Trypanosoma                (3). trend continued 2010 2011, spp                                                                     attaining roadmap target elimination                                                                         African trypanosomiasis (<1 case/10 000 population)                                                                         forecast 2020 (4).  historically, HAT                                                                         characterized episodic epidemics resurgences;
                                                                         control efforts surveillance, early diag-
Correspondence: Lorna MacLean, Centre Immunology                                                                         nosis treatment domestic animals reduce T. brucei
Infection, Department Biology/Hull York Medical School,              reservoirs tsetse fly control maintained University York, Heslington, York YO10 5YW, UK                       prevent HAT resurgence. 2009, 76  (e-mail: l.m.maclean@dundee.ac.uk).                                     reported HAT cases Democratic
Current address: Lorna MacLean, Drug Discovery Unit, College            Republic Congo (DRC) (5). DRC Life Sciences, University Dundee, Dundee DD1 5EH, UK
Disclosures: 
                                                                        regions experiencing war civil unrest, accurate report-
Received: 29 April 2013                                                 ing HAT problematic result signifi-
Accepted publication: 18 June 2013                                  underestimation disease prevalence (6). Research

© 2013 Authors. Parasite Immunology published John Wiley & Sons                                                         283 open access article terms Creative Commons Attribution License, permits use, distribution reproduction medium, provided original work properly cited.
L. MacLean et al.                                                                                             Parasite Immunology


efforts continued development                programmed interconnected including alterations safer, effective chemotherapy tackle disease.           size shape, surface coat, mitochondrion development
Late-stage T. b. rhodesiense HAT currently treated          kinetoplast position (21, 23, 24). Immunofluorescent
highly toxic melarsoprol, causing 84  deaths           analyses using cell cycle stage–specific cytoskeletal
new 10-day regimen (7). Late-stage T. b. gambiense           markers given insights differentiation process
predominantly treated nifurtimox–eflornithine combi-           procyclic trypomastigote stage tsetse fly
nation therapy (NECT), safer option (8) expensive             midgut salivary gland epimastigote stage. difficult administer (9). addition, improvement           requires asymmetrical cell division cycle, results late-stage diagnostics necessary currently inva-        generation long short daughter cell
sive lumbar puncture required CSF microscopic                complete remodelling subpellicular microtu-
analysis consensus criteria defining             bules prior division. short epimastigote able late-stage infections. HAT clinical features, diagnosis         proliferate attach epithelia reaching salivary
treatment recently reviewed (10).                         glands, long epimastigote appears dead-
   addition clinical relevance, African trypano-        end morphological stage (25, 26). particular somes powerful model organism research            mechanism T. brucei evades mammalian
eukaryotic cell biology, including mechanisms cell               host immune response switching variable surface
division, intracellular trafficking organelle biogenesis        glycoprotein (VSG) coat process known antigenic
(11–14). particular highly motile flagel-        variation, allowing maintain chronic infection
lum, consists axonemal microtubules (9 + 2 dou-            (27–30). clever evasion strategy severely hindered
blet organization) extending basal body covered            development protective vaccine HAT (31). membrane (15–17). flagellum similar                  morphological differences parasite stages
structure protein composition primary cilia         demonstrated clearly using electron microscopy
eukaryotes. review focus imaging                   (EM). Scanning electron micrographs mammalian
technology advanced understanding African                BSF T. b. brucei elongated procyclic form
trypanosomes, model impor-               (PCF), characteristic tsetse fly gut form, shown
tant human pathogen.                                                Figure 1 (32). Electron microscopy used                                                                     examine morphological phenotype following molecular
                                                                    manipulations RNA interference (RNAi) gene VITRO AFRICAN TRYPANOSOME IMAGING
                                                                    deletion homologous recombination. illustrated
African trypanosome morphology ultrastructure              transmission electron micrographs T. b. brucei BSF extensively studied using classic light microscopy,            cells Lister 427 wild type (33) (Figure 1b left (34))
transmission electron microscopy (TEM) scanning                 RNAi mutant line following tetracycline-induced
electron microscopy (SEM). studies revealed              knockdown ARF1 (ADP-ribosylation factor 1) 24 h T. brucei curved elongated cells ranging 12           (Figure 1b right, H. Price unpublished data). Expression 35 lm length 15 35 lm width depending             ARF1 gene essential viability bloodstream life cycle stage (18). Trypanosomes kineto-            T. brucei, TEM used demonstrate para-
plastid species characterized disc-shaped kine-          sites depleted ARF1 protein exhibit number mor-
toplast, network mitochondrial circular DNA inside           phological abnormalities prior cell death, including single large mitochondrion. Adjacent kinetoplast          enlarged flagellar pocket, multiple nuclei internal fla- flagellar pocket, invagination plasma mem-            gella (35). recently, dimensional imaging brane major site exo- endocytosis           electron microscope tomography  dimensional recon- constraints imposed tightly packed subpellicular          structions based serial section electron micrographs)
microtubules (19, 20). single motile flagellum originates         provided wealth information key processes basal body emerges flagellar pocket             organelle structures mechanisms driving
extending anteriorly entire length trypano-          mitosis cytokinesis (reviewed Ref. (36)), struc-  Movie S1 shows movement bloodstream form               ture flagellum understanding bihelical
(BSF) T. brucei incubated human blood. Trypano-                motion (37, 38), kinetoplast duplication cycle (39) cell architecture reviewed Ref. (21), T. brucei      cellular architecture flagellar pocket basal
imaging protocols described Ref. (22).                 body (40).
   life cycle, T. brucei alternates environment         Epifluorescence microscopy confocal microscopy mammalian host tsetse fly vector.              routinely used image transgenic parasites
requires developmental changes precisely              expressing fluorescent reporter proteins (live, immobilized

284                   © 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294
Volume 35, Number 9/10, September/October 2013                                                                 Imaging African Trypanosomes


                                      (b)                                                                       (c)




(d)                                                                  (f)




(e)                                                                        (g)




Figure 1 vitro African trypanosome imaging.   Scanning electron micrographs bloodstream form (BSF) Trypanosoma brucei brucei
strain Lister 427 wild type   procyclic form (PCF) T. b. brucei strain EATRO 1125,  . Bar 2 lm. images originally published Ref. (32). (b) Transmission electron micrographs T. b. brucei BSF parasites, wild type (left) (originally published Ref. (34)) following tetracycline-induced knockdown ARF1 24 h (right). FL, flagellum; FP, flagellar pocket; N, nucleus; K,
kinetoplast; GA, Golgi apparatus. Bar 1 lm. (c) T. b. brucei BSF parasites probed anti tubulin (green) costained DAPI.
Wild type   following tetracycline-inducible RNAi knockdown small GTPase ARL2  . Bar 5 lm. (d)
Immunofluorescence analysis T. b. brucei BSF determine subcellular localization ARL6. images dividing cell  nucleus kinetoplasts) probed anti-TbARL6 (red) anti tubulin (green) costained DAPI (blue). Bar 5 lm. (e)
Trafficking lipophilic dye FM4-64 T. b. brucei PCF. Cells washed PBS treated 40 lM FM4-64 (Life Technologies  Paisley, UK) prior CyGEL immobilization. Samples visualized confocal microscopy, FM4-64 excited 543 nm emission collected 560 nm long pass filter. dye seen plasma membrane flagellar pocket time 0. 15 min, signal appeared endosomal  reaching terminal lysosome 90 min. images originally published Ref. (48). (f) Analysis transgenic T. brucei expressing fluorescent proteins. Flow cytometry analysis visualization confocal
microscopy T. b. brucei GVR35 expressing eGFP costained DAPI (left panel). Ninety percentage cells express high
levels eGFP. Flow cytometry analysis visualization confocal microscopy T. b. rhodesiense IL1852 expressing pHD1034
tdTomato costained DAPI (right panel). 98  cells express high levels tdTomato. Transformants selected 01–1 lg/mL
puromycin. Bar 5 lm. (g) Imaging T. brucei blood–brain barrier (BBB) transmigration vitro. Transgenic fluorescent parasites crossing BBB vitro transwell model [monolayer immortalized human brain microvascular endothelial cells (HBMEC)] captured real time multiphoton microscopy using collagen gel plug basolateral chamber.


 fixed) cells labelled specific antibodies.                wild type ARL2 (ADP-ribosylation factor-like 2)
tools highly informative phenotype determination                    RNAi BSF T. brucei labelled DAPI anti 
following RNAi gene deletion subcellular local-                  tubulin antibody (H. Price, unpublished data). Immunoflu-
ization studies. Analysis DAPI-stained T. brucei cells                   orescence SEM data revealed knockdown used combination flow cytometry SEM                      small GTPase ARL2 causes defect cytokinesis result- determine stage specific proteins play role                ing multinucleated, multiflagellated cells (43). Indirect cell cycle (41, 42). Figure 1(c) shows confocal images                  immunofluorescence transmission immunoelectron

© 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294                              285
L. MacLean et al.                                                                                            Parasite Immunology


microscopy techniques employed subcellu-          motility essential viability BSF T. brucei (13).
lar localization small GTPase ARL6 BSF                technique does allow reproducible live cell
T. b. brucei (Figure 1d; H. Price, unpublished data) (44).         imaging L. major PCF T. brucei, facilitat- humans, ARL6 encoded BBS3, 17 genes                ing real-time capture fundamental eukaryotic cellular
implicated genetic disorder Bardet–Biedl syndrome.          processes individual cell level.
ARL6 binds directly BBSome protein complex                 used live cell imaging FRAP analyses required recruitment complex primary cilia       related kinetoplastid Leishmania study export
(45). Unexpectedly, imaging studies T. brucei         pathway hydrophilic acylated surface protein B  
ARL6 parasite associated flagellum,         PB). Hydrophilic acylated surface protein B instead located electron-dense vesicles          expressed infective parasite stages (49, 50)  parasite cell body (44).                                   small hydrophilic endoplasmic reticulum–associated
                                                                   protein (SHERP), essential metacyclogenesis                                                                    sand fly vector (51). Hydrophilic acylated surface protein
LIVE CELL IMAGING
                                                                   B immunogenic promising vaccine candidate
Live cell imaging invaluable tool real-time analy-       (52, 53). Hydrophilic acylated surface protein B sis fundamental processes, including molecular traffick-        nonclassically secreted protein, requiring N-terminal dual
ing. possible subject live kinetoplastid              acylation trafficking plasma membrane (54). parasites advanced microscopy techniques                address mechanism involved, used FRAP fluorescence recovery photobleaching (FRAP)              investigate lateral diffusion reporter fusion protein
fluorescence resonance energy transfer (FRET)              HASPB18-GFP detected parasite body,
analysis molecular diffusion protein complexing             plasma membrane, flagellar pocket flagellum. Small
(46). Development live imaging techniques allowed           regions (ROI) plasma membrane study highly dynamic processes parasite           photobleached, rate mobility percent-
real time, intraflagellar transport (IFT), flagel-       age recovery used indication speed lum-/cilium-specific mechanism conveying molecules          movement percentage mobile vs. immobile mol- distal tip organelle defined           ecules. addition, corresponding fluorescence loss
particles. FRAP spinning disc microscopy                  induced photobleaching (FLIP) additional regions
recently used measure speed IFT particle            outside bleached ROI allowed analysis movement flagella T. brucei procyclic cells              HASPB18-GFP movement direction. FRAP small
expressing green fluorescent protein (GFP)-tagged IFT52            ROI cell body plasma membrane showed recovery
(47). elegant study demonstrated IFT movement            64  48 s, corresponding FLIPs detected extremely fast trypanosome flagella showed           sides ROI illustrated HASPB18-GFP presence independent populations                undergo bidirectional movement inner leaflet anterograde IFT trains travelling single flagella,         membrane [Movie S2; (55)]. Interestingly, FRAP common fusion events  Mathematical                 main cell body (leaving external section modelling using data predicted 45           flagellum unbleached) revealed rapid recovery fluores-
IFT protein pool actively used flagellar transport           cence (6 s) short region flagellum fla-
(47), indicating proteins func-          gellar pocket, fluorescence plasma membrane
tions cell.                                                 did recover 37 min following photobleaching.    obvious problem live imaging trypano-               suggests presence diffusion barrier base somes cells highly motile flagella,       Leishmania flagellum restricts movement types imaging, need firmly immobilized          flagellar proteins cell body membrane [Movie S3; compromising viability. Recently, validated           (55)]. CyGEL immobilization parasites coupled new rapid method immobilizing T. brucei Leish-             FRAP analysis valuable tool studying bar-
mania parasites using thermoreversible gel CyGEL                 rier gain better understanding mechanism
(Biostatus  Shepshed, UK) (48). CyGEL liquid                flagellar trafficking T. brucei Leishmania. ice-cold forms solid matrix warming                CyGEL act controlled delivery 15°C  Leishmania major PCF T. b. brucei              range fluorescent probes PCF T. brucei maintained high level cell viability (>95 ) following       L. major. include intercalating agent propidium
2-h incubation CyGEL. Unfortunately, immobilization             iodide (excitation/emission maxima: 535/617 nm) BSF T. brucei CyGEL caused 90  death 1 h              evaluate cell viability subcellular markers Lysotracker,
(48), supporting studies shown                Mitotracker FM4-64 [N-(3-triethylammoniumpropyl)-

286                  © 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294
Volume 35, Number 9/10, September/October 2013                                                       Imaging African Trypanosomes


4-(6-(4-(diethylamino) phenyl) hexatrienyl) pyridinium              (63), generated T. b. brucei GVR35 (strain used dibromide] (48). monitored uptake lipophilic          murine late-stage HAT model (64)) expressing eGFP
styryl dye FM4-64 (excitation/emission maxima: 515/                 (excitation/emission maxima: 488/507 nm) T. b. rhodes-
640 nm; Life Technologies, Paisley, UK) PCF T. brucei.           iense IL1852 (originally isolated CSF patient
Cells immobilized CyGEL incubated                  Kenya) expressing pHD1034 tdTomato (excitation/
40 lM FM4-64 90-min time course. Trypanoso-                  emission maxima: 554/581 nm) (Figure 1f; L. MacLean,
ma brucei imaged using Zeiss LSM510 Meta confo-              unpublished data; plasmid pHD1034, gift cal microscope. time, dye moves cell            Mackey, Virginia Tech, USA). Ongoing work involves
body membrane flagellar pocket lysosome              incubation fluorescent parasites blood endosomal (Figure 1e; (48)).                             BBB model transwell (composed monolayer    Multiphoton microscopy particularly useful live           immortalized human BMEC, gift K. S. Kim, D.
cell imaging longer wavelength low-energy exci-          Grab, Johns Hopkins University, USA), addition col-
tation lasers harmful, allowing cells imaged         lagen gel plug basolateral chamber imaging para- longer periods confocal microscopy. Used              site transmigration real time using multiphoton
typically 2-photon mode, approach significant         microscopy (Figure 1g). Generating vitro model sys-
advantage exciting fluorophores focal point          tems important order gain insights poorly excitation beam, negating requirement pin-         understood, critical event HAT leading morbidity
hole improving efficiency excitation/emission            mortality.
power (56). advantages, combined reduced                    situ imaging transgenic T. brucei lines expressing
light scattering adsorption excitation light          fluorescent proteins valuable tool study-
near infrared spectrum, improve imaging depth com-            ing development parasite tsetse fly vector.
plex (e.g. organoid) cultures (56). Combining                  Studies flies infected parasite lines express-
advanced imaging technology generation trans-           ing GFP red fluorescent protein showed genic fluorescent T. brucei vitro BBB model (57,          subpopulation yellow hybrids produced sali-
58) allows tackle challenge mimicking              vary glands vector. provided evidence
investigating CNS invasion African trypanosomes                  showing site T. brucei genetic exchange vitro, critical event HAT disease. Little known        occurs, knowledge direct relevance understand- mechanism trypanosome CNS invasion.                    ing population genetics parasite (65, 66).
Access post-mortem human brain tissue limited;  majority work area 
                                                                    VIVO AFRICAN TRYPANOSOME IMAGING
formed mouse models vitro studies. BBB composed endothelial cells line cerebral mi-         vitro models invaluable tools, vivo
crovessels surrounded basal lamina astrocytic peri-          studies required provide insight host–parasite
vascular endfeet. Brain microvascular endothelial cells             interplay reveal details mechanisms involved
(BMEC) form complex tight junctions endothe-              T. brucei CNS invasion subsequent disease progres-
lial cells peripheral tissues, restricting      sion. Evidence HAT mouse models reveals ment small molecules (59). thought          host neuroinflammatory response plays role determin-
parasite host factors affect BBB integrity.         ing trypanosome entry CNS. T. b. brucei-
proposed studies using vitro BBB model              infected mice, IFN-c shown facilitate T-cell brucipain, trypanosome cysteine protease, induces cal-            parasite crossing glia limitans (basement mem-
cium activation signals BMEC protease-activated              brane), parasites captured sets
receptors (PARs), causing brain endothelial bar-            basement membranes IFN-c IFN-c receptor–
rier dysfunction allows trypanosome BBB transmigra-            deficient mice (67). Furthermore, work HAT path-
tion (58).                                                          ogenesis Uganda high levels systemic
   possible use stably transfected T. brucei (60)     IFN-c patients associated increased disease
tool study T. brucei BBB transmigration real time.         severity (68). recent study employed contrast-
used DNA constructs based plasmid vector                     enhanced magnetic resonance imaging (MRI) pHD1034 (61, 62)  integrates parasite gen-           integrity BBB compromised late-stage
ome downstream ribosomal RNA promoter),                   trypanosomiasis mouse model asso-
order produce transgenic lines constitutively expressing         ciated presence severe neuroinflammatory
fluorescent proteins parasite life cycle stages. Using       reaction (69). point, effects trypanosome efficient AMAXA nucleofection transfection protocol             infection BBB integrity remained equivocal 
© 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294                287
L. MacLean et al.                                                                                                        Parasite Immunology


study, late-stage rat model infection, detecting nei-              assume early-stage drugs gain entry CNS
ther loss tight junction proteins occludin zona                  effectively cure late-stage disease. Unfortunately, occludens-1 leakage albumin brain (70).                 case, treatment early-stage
contrast, second investigation significant                   drugs does reduce parasite burden brain
progressive BBB leakage demonstrated presence                    (J. Rodgers, unpublished data), population parasites fluorescent dye brain parenchyma following                        remains following treatment. combining MRI peripheral intravenous injection (71). MRI                     state art microscopy techniques detailed benefits conventional histological                      review, possible identify areas biochemical techniques. example, MRI allows imaging                    CNS harbour residual population select brain identify specific regions                    areas specific ROI MRI analyses. Furthermore,
altered BBB integrity. Furthermore, process                  tracking parasite transmigration CNS, ducted vivo, precludes occurrence artefacts                 feasible determine BBB leakage associ- result following death animal.                   ated trypanosome infections direct product  greatest advantage MRI ability                 trypanosome traversal barrier product technique monitor integrity barrier                ongoing peripheral inflammatory response. single animal predefined time course infection                    far, paucity data route treatment. methodology successfully                       T. brucei primary CNS invasion sequential 
applied demonstrate rapid restoration BBB func-                  ment maintenance parasites brain dis-
tion following curative course novel oral formula-                  ease progresses. previous comprehensive morphological
tion trypanocidal drug melarsoprol (72).                    study experimental cerebral trypanosomiasis (73) analy-
MRI shown significant reduction BBB integrity                     sed histopathology mouse brain serial sections
following trypanosome infection, logical                    animals infected T. b. brucei LUMP 227 


Figure 2 Detection Trypanosoma brucei brucei GVR35 eGFP central nervous (CNS). T. b. brucei expressing GVR35 eGFP passaged female CD-1 mouse intraperitoneal inoculation 1 9 105 parasites HMI-9 media. day 10 post-infection, trypanosomes harvested 4 9 104 parasites passaged second mouse. 28 days, mouse exsanguinated cardiac puncture brain excised  vivo experiments authorized United Kingdom Animals (Scientific
Procedures) Act 1986 approved University Glasgow Ethical Review Committee].   Graphical representation neuropathology grade days 7–28 post-infection T. b. brucei GVR35 wild type (grey) eGFP transgenic parasites (green). severity neurological reaction T. brucei infection determined neuropathology grading scale 0 4. Briefly, haematoxylin eosin–stained sections hippocampal brain region examined. Normal brain classified grade 0, mild meningitis grade 1, moderate meningitis perivascular cuffing grade 2, severe meningitis perivascular cuffing inflammatory cells neuropil grade 3 severe meningoencephalitis inflammatory cells parenchyma grade 4.
(Boxes represent mean values, whiskers represent standard error.). (b) Graphical representation parasite load mouse brain days 7–28 post-infection T. b. brucei GVR35 wild type (grey) eGFP transgenic parasites (green). Parasite load determined Taqman-PCR detect T. brucei paraflagellar rod (PFR) 2 gene using brains. (c) Confocal microscopic analysis mount
day 28 post-infection brain sections. Following fixation 04  paraformaldehyde, brain embedded 8  agarose PBS axial sections (200 lm  obtained using Leica VT 1000S vibratome. Tissue sections blocked 5  goat serum/015  Triton
X-100/PBS 60 min incubated primary antibodies, mouse antismooth muscle actin (Sigma-Aldrich  detect vasculature rabbit antineurofilament 200 (Sigma-Aldrich) dilution 1 : 500, 24 h. Sections washed 015  Triton
PBS 9 3 left overnight wash buffer 4°C. Secondary antibodies goat anti-mouse Alexa 594 (pink) goat anti-rabbit Alexa 488
(green) added dilution 1 : 500 incubated 24 h. Sections washed blocked 5  rabbit serum/015 
Triton X-100/PBS 60 min, incubated rabbit anti-green fluorescent protein (GFP) Alexa 647 (red) 1 : 500 dilution (Life
Technologies) 24 h. Sections washed  fixed 4  PFA 15 min room temperature washed times 30 min. Sections gradually dehydrated successive concentrations methanol PBS–Triton X-100 subsequently incubated benzyl alcohol/benzyl benzoate (Sigma-Aldrich  (BABB) MeOH dilution 50  BABB 50  MeOH 10–15 min room temperature glass containers. Finally, sections left 100  BABB 25 min mounted metal slides large opening drilled centre coverslip attached using nail varnish. depression filled fresh
BABB sample transferred slide. coverslip placed sealed nail varnish. Sections analysed
using Zeiss LSM710 Meta invert confocal microscope using EC Plan-Neofluar 109/03 LD C-Apochromat 409/11W objective lens. white box left-hand image represents region shown higher magnification images right. T. b. brucei
GVR35 expressing eGFP shown present meninges forebrain (ci) cerebellum (cii) brain
parenchyma (ciii) day 28 pi. confirmed rabbit anti-GFP Alexa 647 labelling (red). (d) Confocal microscopic analysis 
mount day 2 post-infection brain sections. Axial brain sections prepared Figure 2c;  sections labelled rabbit anti-GFAP antibody  detected Alexa 594 (pink) visualize astrocytes. T. b. brucei GVR35 expressing eGFP detected cerebellar parenchyma day 2 post-infection.


288                     © 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294
Volume 35, Number 9/10, September/October 2013                                                       Imaging African Trypanosomes


1–9 weeks using haematoxylin eosin staining. Immu-              et al. proposed route parasite invasion
nofluorescence performed frozen brain                   brain migration vascular com-
sections, parasites labelled antitrypanoso-         partment choroid plexus interstitium, aided mal antibodies  LUMP227 antigens) detected              increased permeability choroid plexus vessels compared fluorescein-conjugated secondary antibody. histo-          cerebral vessels (74), subsequent invasion addi-
pathology revealed parasites cho-       tional brain structures following initiation local
roid plexuses (lateral fourth) weeks 3–4, mainly          inflammatory reaction choroid plexus. interstitium lumen wall vessels,           possible use transgenic fluorescent T. brucei
small number meninges usually week 6.           combination mount labelling tissue immunofluorescence, parasites detected slightly             sections (100–200 lm) cut using vibrating blade (vibra-
earlier choroid plexuses week 2              tome) confocal microscopy sensitive method meninges week 4. advanced cases, large numbers              detecting T. brucei brain. GVR35 eGFP clones parasites choroid plexuses, perivas-        assessed flow cytometry quantify level cular spaces occasionally white matter. Poltera          fluorescence. best clone, 99  GVR35 eGFP



                                                         (b)
                        




                       (c)
                         




                       (ii)




                       (iii)




                       (d)




© 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294                289
L. MacLean et al.                                                                                            Parasite Immunology


population shown express high level eGFP              24 h infection significant microvascular inflamma-
(Figure 1f), establishing infection 28 days,         tion observed (77). findings particular
GVR35 eGFP parasites detected wet blood film             recently reported neurological symptoms
using fluorescence microscopy (J. Rodgers, unpublished             patients presenting early-stage T. b. rhodesiense
data). severity neurological response T. bru-        infections (78).
cei infection determined neuropathology grading              studies demonstrate fluorescent parasites scale 0 4 previously described (75). GVR35              GVR35 eGFP invaluable tool wild type eGFP transgenic parasites showed compara-            investigation African trypanosomes mammalian
ble levels neuropathology days 7–28 post-infection,          host, including live vivo imaging late-stage HAT,  exhibiting increase time displaying mod-          passaged, tsetse fly transmission vector.
erate meningitis perivascular cuffing day 28
(Figure 2a; J. Rodgers, unpublished data).                                                                     ANIMAL VIVO (IVIS) IMAGING
transgenic line valid tool analysing CNS infection.
Parasite load determined brains real-time          development live animal imaging trans-
quantitative PCR described previously (72) amplifi-          genic mouse models particularly useful visual-
cation paraflagellar rod (PFR) 2 gene,             izing T. brucei dissemination host specific kinetoplastids. Similar trends increasing           inoculation site local lymph nodes, establishing blood-
parasite load time following infection             stream infection subsequently CNS infection. Imaging wild type eGFP-expressing GVR35 parasite lines            studies allow examine host responses infec-
(Figure 2b; J. Rodgers, unpublished data).                         tion animal level great importance.
   Using brain antineurofilament antibody labelling,               Various reporter trypanosome lines expressing biolumines-
detected goat anti-rabbit Alexa 488 (green), pos-        cent proteins generated years
sible obtain overview day 28 post-infection axial         enable noninvasive imaging trypanosome
brain sections using confocal microscopy (Figure 2c left           infections mice. Claes et al. (79) Giroud et al. (80)
panel, white box represents enlarged area right panel;          described generation T. b. brucei 427, T. b. brucei
L. MacLean, unpublished data). Looking higher mag-            AnTat1.1 T. b. gambiense lines expressing Renilla
nification, detected eGFP (excitation  488 nm,          luciferase. use bioluminescence imaging, green) confirmed anti-GFP/Alexa 647 (red) label-            progression dissemination infection ling, apparent eGFP-expressing T. brucei          tracked vivo localization specific organs shown
abundant particularly meninges forebrain             ex vivo imaging. recently, firefly luciferase
(Figure 2c  cerebellum (Figure 2c ii)         variant LUC2 (Promega) employed cerebellar parenchyma (Figure 2c iii). Preliminary analysis        imaging T. b. brucei infections. brains isolated mice day 2 post-infection,                 monitoring acute infections provides fast method
labelled rabbit anti-GFAP 594 (pink) detect glial          test compounds stage trypanosomiasis, fibrillary acidic protein, main intermediate filament          new drugs second CNS stage disease
protein expressed astrocytes, revealed GVR35 eGFP               urgently required. current model trypano-
parasites cerebellar parenchyma (Figure 2d), sug-           CNS infections makes use GVR35 strain gesting trypanosome CNS invasion occurs                T. b. brucei, establishes CNS infection 21 days
neurological signs detected. Studies underway           post-infection (64). original model, mice treated
analyse early invasion determine para-       test compounds 21 days post-infection moni-
site distribution kinetics disease progression using        tored 180 days treatment assessing blood para-
GVR35 eGFP-infected mice. Following labelling, sec-           sitaemia. modified T. b. brucei GVR35 stably
tions brain imaged using fully automated slide      express firefly luciferase (LUC2), allowing moni-
scanner, allows rapid analysis serial brain sections      toring CNS-stage infections chemotherapy vivo time points. Detection parasites brain        imaging (Figure 3). substrate firefly luciferase, quickly following infection supports Frevert et al.s          D-luciferin, readily crosses BBB, making reporter
work using intravital confocal microscopy. study,          best choice high-sensitivity bioluminescence imaging
green fluorescent cell tracker dye PKH67-labelled T. brucei        brain. Treatment GVR35-LUC2-infected mice (excitation/emission maxima: 490/502 nm; Sigma-Aldrich             curative dose melarsoprol (81) abolished biolumines-  Dorset, UK) monomeric mOrange-expressing               cence. contrast, mice treated DB75 [2,5-bis(4-
T. brucei (excitation/emission maxima: 548/562 nm; (61,            amidinophenyl)furan], compound shown ineffective
76)) detected mouse brain parenchyma            CNS trypanosomes (82), bioluminescence 
290                  © 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294
Volume 35, Number 9/10, September/October 2013                                                                 Imaging African Trypanosomes



  




 (b)




Figure 3 Bioluminescence imaging assess chemotherapy stage 2 trypanosomiasis. Mice injected intraperitoneally 3 9 104
Trypanosoma brucei brucei GVR35-LUC2 bloodstream form (BSF) parasites treated 21 days post-infection   melarsoprol
(topical application 36 mg consecutive days) (b) DB75 (20 mg/kg consecutive days intraperitoneally). Mice imaged indicated times infection using IVIS Spectrum (PerkinElmer, Waltham, MA, USA). D-Luciferin (150 mg/kg) injected
intraperitoneally 10 min prior imaging. Bioluminescence shown total flux photons second (p/s) parasitaemia mouse shown image ND indicating trypanosomes detected blood samples. representative mice shown entire period. colour scales used treatments indicate strong   weaker (b) bioluminescent radiance photons/s/cm2/steradian.


detected heads treated mice increased              biology, rapid progress understand-
spread cervical lymph nodes eventually rest                 ing biology lethal pathogens. Emerging body. new imaging model, bioluminescent                      super-resolution microscopy techniques including stimu-
trypanosomes detected weeks detection                 lated emission depletion (STED), photoactivated light blood, providing significant improvement                  microscopy (PALM) stochastic optical reconstruction
post-treatment time required establish promis-               microscopy (STORM) enable detailed structure ing compound effective stage 2 (CNS) trypanosomiasis               studied higher resolution using light microscopy (LM),
(E. Myburgh et al., manuscript submitted).                                narrowing gap LM EM. Multipho-
                                                                          ton imaging enhanced using latest fluo-
                                                                          rescent protein derivatives red-shifted CONCLUSIONS
                                                                          imaged greater depths. excited exploiting recent advances imaging technology,                      longer, deeper penetrating wavelengths emitted light coupled developments molecular cellular                       able escape detector greater depths. 
© 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294                              291
L. MacLean et al.                                                                                                                   Parasite Immunology


addition, new technique Clear Lipid-exchanged Acrylam-                        assistance tissue labelling, Zachary Mackey
ide-hybridized Rigid Imaging/Immunostaining situ                             (Department Biochemistry, Virginia Polytechnic Insti-
hybridization-compatible Tissue-hYdrogel (CLARITY)                          tute State University, USA) plasmid pHD1034
recently used imaging molecular phenotyping                        Dennis Grab Kwang Sik Kim (Department of intact tissue (83). Employing new imaging tools                        Pathology, Johns Hopkins University School Medicine, critical new insight cellular molecular                  Baltimore, USA) HBMEC technical advice basis late (CNS)-stage HAT advance future                            BBB model. thank Deborah Smith, James Brewer
drug development screening programmes.                                      Jeremy Mottram critical reading manu-
                                                                                script. vitro imaging brain section imaging                                                                                 funded Wellcome Trust [077503] VIP Wellcome
ACKNOWLEDGEMENTS
                                                                                Trust-funded University York Departmental fellowship gratefully acknowledge contributions follow-                        [092430 10 . vivo (IVIS) imaging work ing colleagues: Peter OToole (Technology Facility, Univer-                      funded Melinda Gates Foundation
sity York, UK) technical advice helpful                              [OPPGH5337]. Wellcome Trust Centre Molecular
discussions, Priyanka Narang (London School Hygiene                          Parasitology supported core funding Tropical Medicine, Immunology Infection, UK)                            Wellcome Trust [085349].


REFERENCES
1 Blum J, Schmid C & Burri C. Clinical             10 Kennedy PG. Clinical features, diagnosis,               Trypanosoma brucei. Microsc Microanal
  aspects 2541 patients second stage          treatment human African trypanoso-               2004; 10: 621–636.
  human African trypanosomiasis. Acta Trop            miasis (sleeping sickness). Lancet Neurol          23   Portman N & Gull K. Proteomics   2006; 97: 55–64.                                    2013; 12: 186–194.                                      Trypanosoma brucei cytoskeleton: advances
2 Kennedy PGE. Human African trypanoso-            11 Vaughan S & Gull K. structural mechan-              opportunities. Parasitology 2012; 139:
  miasis CNS: current issues chal-         ics cell division Trypanosoma brucei.             1168–1177.
  lenges. J Clin Invest 2004; 113: 496–504.           Biochem Soc Trans 2008; 36: 421–424.               24   Matthews KR. Developments differen-
3 Simarro PP, Cecchi G, Franco JR, et al.          12 Engstler M, Pfohl T, Herminghaus S, et al.              tiation Trypanosoma brucei. Parasitol
  Estimating mapping population            Hydrodynamic flow-mediated protein sorting              Today 1999; 15: 76–80.
  risk sleeping sickness. PLoS Negl Trop           cell surface trypanosomes. Cell          25   Rotureau B, Subota & Bastin P. Molecular
  Dis 2012; 6: e1859.                                 2007; 131: 505–515.                                     bases cytoskeleton plasticity 4  Sustaining Drive Overcome        13 Broadhead R, Dawe HR, Farr H, et al.                    Trypanosoma brucei parasite cycle. Cell
  Global Impact Neglected Tropical Diseases.       Flagellar motility required viability        Microbiol 2011; 13: 705–716.
  Crompton DWT (ed). Second                    bloodstream trypanosome. Nature             26   Sharma R, Peacock L, Gluenz E, Gull K,
  Report Neglected Tropical Diseases.              2006; 440: 224–227.                                     Gibson W & Carrington M. Asymmetric cell
  HTM/NTD/2013.1. 2013.  2012.             14 CY, Ho HH, Malsam J, et al. Golgi                    division route reduction cell length
5 Simarro PP, Cecchi G, Paone M, et al.           duplication Trypanosoma brucei. J Cell               change cell morphology trypano-
  Atlas human African trypanosomiasis:           Biol 2004; 165: 313–321.                                somes. Protist 2008; 159: 137–151.
  contribution global mapping neglected      15 Tyler KM, Fridberg  Toriello KM, et al.          27   Vickerman K & Luckins AG. Localisation
  tropical diseases. Int J Health Geogr 2010; 9:      Flagellar membrane localization associa-            variable antigens surface coat   57.                                                 tion lipid rafts. J Cell Sci 2009; 122:            Trypanosoma brucei using ferritin conjugated
6 Hasker E, Lutumba P, Chappuis F, et al.             859–866.                                                antibody. Nature 1969; 224: 1125–1126.
  Human African trypanosomiasis             16 Hill KL. Parasites motion: flagellum-           28   Vickerman K. Antigenic variation trypan-
  Democratic Republic Congo: loom-           driven cell motility African trypanosomes.           osomes. Nature 1978; 273: 613–617.
  ing emergency? PLoS Negl Trop Dis 2012; 6:          Curr Opin Microbiol 2010; 13: 459–465.             29   Rudenko G. African trypanosomes: gen-
  e1950.                                           17 Vaughan S. Assembly flagellum            ome adaptations immune evasion.
7 Kuepfer  Schmid C, Allan M, et al. Safety         role cell morphogenesis Trypanosoma               Essays Biochem 2011; 51: 47–62.
  efficacy 10-day melarsoprol sche-        brucei. Curr Opin Microbiol 2010; 13: 453–458.     30   Horn D & McCulloch R. Molecular mecha-
  dule treatment second stage Rho-      18 Hoare CA. Trypanosomes Mammals:                  nisms underlying control antigenic
  desiense sleeping sickness. PLoS Negl Trop          Zoological monograph. Oxford, Blackwell               variation African trypanosomes. Curr
  Dis 2012; 6: e1695.                                 Scientific Publications, 1972.                          Opin Microbiol 2010; 13: 700–705.
8 Alirol E, Schrumpf D, Amici Heradi J,            19 Overath P & Engstler M. Endocytosis, mem-          31   La Greca F & Magez S. Vaccination   et al. Nifurtimox-eflornithine combination          brane recycling sorting GPI-anchored             trypanosomiasis:   therapy second-stage gambiense human            proteins: Trypanosoma brucei model                 trypanosome truly ultimate immune
  African trypanosomiasis: medecins sans               Mol Microbiol 2004; 53: 735–744.                destroyer escape artist? Hum Vaccin
  frontieres experience democratic          20 Field MC & Carrington M. trypano-                   2011; 7: 1225–1233.
  republic congo. Clin Infect Dis 2013;        flagellar pocket. Nat Rev Microbiol           32   Price HP, Hodgkinson MR, Curwen RS,
  56: 195–203.                                        2009; 7: 775–786.                                       et al. orthologue Sjogrens syndrome
9 Simarro PP, Franco J, Diarra  Postigo JA       21 Matthews KR. developmental cell                     nuclear autoantigen 1 (SSNA1) Trypanosoma
  & Jannin J. Update field use avail-       biology Trypanosoma brucei. J Cell Sci               brucei immunogenic self-assembling
  able drugs chemotherapy human            2005; 118: 283–290.                                     molecule. PLoS 2012; 7: e31842.
  African trypanosomiasis. Parasitology 2012;      22 Field MC, Allen CL, Dhir V, et al. New             33   Wirtz E, Leal S, Ochatt C & Cross GA.   139: 842–846.                                       approaches microscopic imaging                tightly regulated inducible expression 


292                       © 2013 Authors. Parasite Immunology published John Wiley & Sons  Parasite Immunology, 35, 283–294
Volume 35, Number 9/10, September/October 2013                                                                             Imaging African Trypanosomes


     conditional gene knock-outs domi-          49 Flinn HM, Rangarajan D & Smith DF.                    stream forms Trypanosoma brucei. Mol
     nant-negative genetics Trypanosoma bru-            Expression hydrophilic surface protein           Biochem Parasitol 2007; 153: 220–223.
     cei. Mol Biochem Parasitol 1999; 99: 89–101.          infective stages Leishmania major. Mol     64   Jennings FW & Gray GD. Relapsed para-
34   Price HP, Goulding D & Smith DF. ARL1                 Biochem Parasitol 1994; 65: 259–270.                  sitaemia following chemotherapy chronic
     essential role Trypanosoma brucei.       50 Depledge DP, MacLean LM, Hodgkinson                   T. brucei infections mice relation
     Biochem Soc Trans 2005; 33: 643–645.                  MR, et al. Leishmania-specific surface anti-          cerebral trypanosomes. Contrib Microbiol
35   Price HP, Stark M & Smith DF. Trypanoso-              gens sub-genus sequence variation            Immunol 1983; 7: 147–154.
     ma brucei ARF1 plays central role                immune recognition. PLoS Negl Trop Dis           65   Peacock L, Ferris V, Bailey M & Gibson W.
     endocytosis golgi-lysosome trafficking.           2010; 4: e829.                                        Intraclonal mating occurs tsetse
     Mol Biol Cell 2007; 18: 864–873.                   51 Sadlova J, Price HP, Smith BA, Votypka J,             transmission Trypanosoma brucei. Parasit
36   Farr H & Gull K. Cytokinesis trypano-              Volf P & Smith DF. stage-regulated                Vectors 2009; 2: 43.
     somes. Cytoskeleton (Hoboken) 2012; 69:               HASPB SHERP proteins essential           66   Peacock L, Ferris V, Bailey M & Gibson W.
     931–941.                                              differentiation protozoan parasite         Dynamics infection competition
37   Koyfman AY, Schmid MF, Gheiratmand L,                 Leishmania major sand fly vector, Phle-        strains Trypanosoma brucei
     et al. Structure Trypanosoma brucei flagel-        botomus papatasi. Cell Microbiol 2010; 12:            brucei tsetse fly observed using
     lum accounts bihelical motion. Proc           1765–1779.                                            fluorescent markers. Kinetoplastid Biol Dis
     Natl Acad Sci USA 2011; 108: 11105–11108.          52 Stager S, Smith DF & Kaye PM. Immuniza-               2007; 6: 4.
38   Hoog JL, Bouchet-Marquis C, McIntosh                  tion recombinant stage-regulated sur-     67   Masocha W, Robertson B, Rottenberg 
     JR, Hoenger & Gull K. Cryo-electron                 face protein Leishmania donovani                 Mhlanga J, Sorokin L & Kristensson K.
     tomography 3-D analysis intact             induces protection visceral leishmani-        Cerebral vessel laminins IFN-gamma
     flagellum Trypanosoma brucei. J Struct             asis. J Immunol 2000; 165: 7064–7071.                 define Trypanosoma brucei brucei penetration
     Biol 2012; 178: 189–198.                           53 Maroof  Brown N, Smith B, et al. Thera-             blood-brain barrier. J Clin Invest
39   Gluenz E, Povelones ML, Englund PT &                  peutic vaccination recombinant adeno-            2004; 114: 689–694.
     Gull K. kinetoplast duplication cycle          virus reduces splenic parasite burden         68   MacLean L, Odiit M, Macleod  et al.
     Trypanosoma brucei orchestrated cyto-           experimental visceral leishmaniasis. J Infect         Spatially genetically distinct African
     skeleton-mediated cell morphogenesis. Mol             Dis 2012; 205: 853–863.                               Trypanosome virulence variants defined      Cell Biol 2011; 31: 1012–1021.                     54 Denny PW, Gokool S, Russell DG, Field                 host interferon-c response. J Infect Dis 2007;
40   Lacomble S, Vaughan S, Gadelha C, et al.              MC & Smith DF. Acylation-dependent pro-               196: 1620–1628.
     dimensional cellular architecture            tein export Leishmania. J Biol Chem           69   Rodgers J, McCabe C, Gettinby G, Bradley
     flagellar pocket associated cytoskele-        2000; 275: 11017–11025.                               B, Condon B & Kennedy PG. Magnetic
     ton trypanosomes revealed electron           55 Maclean LM, OToole PJ, Stark M, et al.                resonance imaging assess blood-brain
     microscope tomography. J Cell Sci 2009;               Trafficking release Leishmania meta-           barrier damage murine trypanosomiasis.
     122: 1081–1090.                                       cyclic HASPB macrophage invasion. Cell             J Trop Med Hyg 2011; 84: 344–350.
41   Hammarton TC, Monnerat S & Mottram                    Microbiol 2012; 14: 740–761.                     70   Mulenga C, Mhlanga JDM, Kristensson K
     JC. Cytokinesis trypanosomatids. Curr           56 Squirrell JM, Wokosin DL, White JG &                  & Robertson B. Trypanosoma brucei brucei
     Opin Microbiol 2007; 10: 520–527.                     Bavister BD. Long-term photon fluores-            crosses blood-brain barrier tight
42   Hammarton TC, Clark J, Douglas F,                     cence imaging mammalian embryos               junction proteins preserved rat
     Boshart M & Mottram JC. Stage-specific                compromising viability. Nat Biotechnol            chronic disease model. Neuropathol Appl
     differences cell cycle control Trypanoso-       1999; 17: 763–767.                                    Neurobiol 2001; 27: 77–85.
     ma brucei revealed RNA interference        57 Grab DJ, Nikolskaia O, Kim YV, et al. Afri-      71   Philip KA, Dascombe MJ, Fraser PA &
     mitotic cyclin. J Biol Chem 2003; 278:                trypanosome interactions vi-           Pentreath VW. Blood-brain-barrier damage
     22877–22886.                                          tro model human blood-brain barrier.           experimental African trypanosomiasis.
43   Price HP, Peltan  Stark M & Smith DF.               J Parasitol 2004; 90: 970–979.                        Ann Trop Med Parasitol 1994; 88: 607–616.
     small GTPase ARL2 required              58 Grab DJ, Garcia-Garcia JC, Nikolskaia OV,        72   Rodgers J, Jones  Gibaud S, et al. Melar-
     cytokinesis Trypanosoma brucei. Mol Bio-           et al. Protease activated receptor signaling          soprol cyclodextrin inclusion complexes      chem Parasitol 2010; 173: 123–131.                    required African trypanosome tra-              promising oral candidates treatment
44 